Sep 03 • 8 months ago
OTC nasal spray seemed to cut COVID infections by 67% in mid-sized trial
The Phase 2 trial is not definitive, but it comes as vaccine access is severely restricted. ...
{"_":"https://arstechnica.com/health/2025/09/otc-nasal-spray-seemed-to-cut-covid-infections-by-67-in-mid-sized-trial/","$":{"isPermaLink":"true"}}2 min read
Read More